Tyrosine Kinases as Targets for Cancer TherapyDaniela S. Krause, Richard A. Van Etten|New England Journal of Medicine|2005Cited by 1.4k
Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617FVirginia M. Zaleskas, Richard A. Van Etten|PLoS ONE|2006Cited by 215
Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapyJonathan Rodriguez, Richard A. Van Etten|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 3
Tu1515: CLIMB: A PROSPECTIVE, BLINDED, MULTICENTER U.S. BASED STUDY EVALUATING A MULTI-ANALYTE BLOOD-BASED TEST FOR DETECTING HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH LIVER CIRRHOSISDavid J. Taggart, Mindie H. Nguyen, Maxime A. Gallant et al.|Gastroenterology|2025Cited by 1